Anavex Life Sciences Corp (AVXL)

[AlchemicalVoyager13]

@ Investor2014 First, are you British? (defence rather than defense)
I firmly believe that a CMA will be green lighted. The EU can not afford to have this drug available to the masses and furthermore have approved two others with far lesser efficacy at a high cost/patient. I believe the 3-4 year OLE serves as an additional P3 trial without doubt. And it had patient benefit of no placebo.
To not approve Blar will cost member countries billions upon billions in additional patient care expenses per annum. I realize that is not in the forefront of the decision making process but is reality.